SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

SEC Comment Letter 0000000000-24-000294 to China Health Industries Holdings, Inc. (CHHE) (CIK 0001309057)

China Health Industries Holdings, Inc. (CHHE) (CIK 0001309057)
Date: Jan. 9, 2024 · CIK: 0001309057 · Accession: 0000000000-24-000294

AI Filing Summary & Sentiment

File numbers found in text: 000-51060

Date
January 9, 2024
Author
Not clearly detected
Form
UPLOAD
Company
China Health Industries Holdings, Inc. (CHHE) (CIK 0001309057)

Letter

United States securities and exchange commission logo January 9, 2024 Xin Sun Chief Executive Officer China Health Industries Holdings, Inc. 3199-1 Longxiang Road, Songbei District, Harbin City Heilongjiang Province People’s Republic of China Re:China Health Industries Holdings, Inc. Form 10-K for Fiscal Year Ended June 30, 2023 File No. 000-51060 Dear Xin Sun: We have reviewed your January 8, 2024 response to our comment letter and have the following comment. Please respond to this letter within ten business days by providing the requested information or advise us as soon as possible when you will respond. If you do not believe a comment applies to your facts and circumstances, please tell us why in your response. After reviewing your response to this letter, we may have additional comments. Unless we note otherwise, any references to prior comments are to comments in our December 27, 2023 letter. Form 10-K for Fiscal Year Ended June 30, 2023 Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections, page 30 1.We note your statement that you reviewed your shareholders' list in connection with your required submission under paragraph (a). Please supplementally describe any additional materials that were reviewed and tell us whether you relied upon any legal opinions or third party certifications such as affidavits as the basis for your submission. Please contact Charlie Guidry at 202-551-3621 or Christopher Dunham at 202-551-3783 with any other questions. Sincerely, Division of Corporation Finance Disclosure Review Program cc: Elizabeth Fei Chen

Show Raw Text
United States securities and exchange commission logo
January 9, 2024
Xin Sun
Chief Executive Officer
China Health Industries Holdings, Inc.
3199-1 Longxiang Road, Songbei District, Harbin City
Heilongjiang Province
People’s Republic of China
Re:China Health Industries Holdings, Inc.
Form 10-K for Fiscal Year Ended June 30, 2023
File No. 000-51060
Dear Xin Sun:
            We have reviewed your January 8, 2024 response to our comment letter and have the
following comment. Please respond to this letter within ten business days by providing the
requested information or advise us as soon as possible when you will respond. If you do not
believe a comment applies to your facts and circumstances, please tell us why in your response.
After reviewing your response to this letter, we may have additional comments. Unless we note
otherwise, any references to prior comments are to comments in our December 27, 2023 letter.
Form 10-K for Fiscal Year Ended June 30, 2023
Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections, page 30
1.We note your statement that you reviewed your shareholders' list in connection with your
required submission under paragraph (a). Please supplementally describe any additional
materials that were reviewed and tell us whether you relied upon any legal opinions or
third party certifications such as affidavits as the basis for your submission.
            Please contact Charlie Guidry at 202-551-3621 or Christopher Dunham at 202-551-3783
with any other questions.
Sincerely,
Division of Corporation Finance
Disclosure Review Program
cc:       Elizabeth Fei Chen